The France Foundation relies upon faculty members to provide educational information in a manner that is objective and free from bias. In compliance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Commercial Support, all faculty members are required to disclose any conflicts of interest related to the context of their participation in a CME activity. Faculty members have disclosed the following relationship(s) with commercial interests:

Michael H. Allen, MD, is a consultant for Abbott Laboratories, Alexza Pharmaceuticals, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, and Pfizer Inc. He has received research funding and grants from Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Janssen Pharmaceutica Products, and Pfizer Inc.

Claudia F. Baldassano, MD, has served as a speaker for AstraZeneca Pharmaceuticals, GlaxoSmithKline, and Pfizer Inc.

Peter F. Buckley, MD, has served as a consultant for and/or has received honoraria from Abbott Laboratories, Alamo Pharmaceuticals, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Janssen Pharmaceutica Products, Merck, and Pfizer Inc. He has received grant and research support from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Janssen Pharmaceutica Products, Pfizer Inc, and Solvay.

Joseph R. Calabrese, MD, has received funding from Abbott Laboratories, AstraZeneca Pharmaceuticals, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Merck, and Pfizer Inc. He has served as a consultant or on advisory boards for Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Otsuka, and Teva Pharmaceutical Industries.

Andrew J. Cutler, MD, has served as a consultant and on speakers bureaus for Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, Otsuka Pharmaceutical, Pfizer Inc, and Shire Pharmaceuticals. He has received research grants from Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson and Johnson, Merck, Organon, Otsuka Pharmaceutical, Pfizer Inc, Sanofi Pharmaceuticals Inc, Shire Pharmaceuticals, Solvay, and Wyeth.

Melissa P. DelBello, MD, has received speaker and consulting honoraria for Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Pfizer Inc, Ortho-McNeil Pharmaceutical Inc, and Shire Pharmaceuticals. Dr. DelBello has received research support from Abbott Laboratories, AstraZeneca Pharmaceuticals, Eli Lilly and Company, Ortho-McNeil Pharmaceuticals, Janssen Pharmaceutica Products, and Pfizer Inc.

S. Nassir Ghaemi, MD, MPH, has served on speakers bureaus for Abbott Laboratories and GlaxoSmithKline. He has served on advisory boards and received research grants from GlaxoSmithKline and Pfizer Inc.

Joseph F. Goldberg, MD, has served on speakers bureaus for Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, and GlaxoSmithKline. He has served on advisory boards for Eli Lilly and Company and GlaxoSmithKline.

Paul E. Keck, Jr, MD, is a consultant to, or member of the scientific advisory boards of: Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Neurocrine, Ortho-McNeil Pharmaceutical Inc,  Pfizer Inc, and Shire Pharmaceuticals. He is a principal or co-investigator on research studies sponsored by: Abbott Laboratories, American Diabetes Association, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Merck, National Institute of Mental Health, National Institute of Drug Abuse, Organon, Ortho-McNeil, Pfizer Inc, the Stanley Medical Research Institute, and UCB Pharma.

Henry A. Nasrallah, MD, has received research grants from AstraZeneca Pharmaceuticals, Eli Lilly and Company, Janssen Pharmaceutica Products, National Institute of Mental Health, and Pfizer Inc. He has served as a consultant and on speakers bureaus and advisory boards for Abbott Laboratories, AstraZeneca Pharmaceuticals, Janssen Pharmaceutica Products, Pfizer Inc, and Shire Pharmaceuticals.

Robert M. Post, MD, has served as a speaker for Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, and Shire Pharmaceuticals. He has served as a consultant for Shire Pharmaceuticals.

Gary S. Sachs, MD, has received grant support from Janssen Pharmaceutica Products and Wyeth. He has served as a consultant for Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Novartis, Sanofi, and Shire Pharmaceuticals. Dr. Sachs has received honoraria from Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Novartis, Pfizer Inc, Sanofi Pharmaceuticals Inc, Solvay, and Wyeth.

S. Charles Schulz, MD, has served as a consultant for AstraZeneca Pharmaceuticals and Eli Lilly and Company, and has served as a speaker for AstraZeneca Pharmaceuticals. He has received grant support from Abbott Laboratories, AstraZeneca Pharmaceuticals, Eli Lilly and Company, and Janssen Pharmaceutica Products.

Alan C. Swann, MD, has served as a consultant and on speakers bureaus for Abbott Laboratories, AstraZeneca Pharmaceuticals, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Novartis, Ortho-McNeil Pharmaceutical Inc, Parke-Davis, Pfizer Inc, and Shire Pharmaceuticals. He has received grant and research support from Abbott Laboratories, CIBA, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, Novartis, Pfizer Inc, Shire Pharmaceuticals, and UCB Pharma.

Richard M. Trosch, MD, has served as a member of the speakers bureau for AstraZeneca Pharmaceuticals.

Disclaimer
The opinions, recommendations, and guidelines expressed herein are those of the MEASURE™ Educational Review Board and not necessarily those of The France Foundation or AstraZeneca Pharmaceuticals, who assume no responsibility or liability for the information that appears herein.